"Tumor-Free Survival" Outweighs the Side Effects of Combined Anti-EGF Therapy and Chemotherapy in Patients With NSCLC.

J Thorac Oncol

Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2024.05.368DOI Listing

Publication Analysis

Top Keywords

"tumor-free survival"
4
survival" outweighs
4
outweighs side
4
side effects
4
effects combined
4
combined anti-egf
4
anti-egf therapy
4
therapy chemotherapy
4
chemotherapy patients
4
patients nsclc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!